Skip to content

Clinical trials

Phase 3 Atherosclerosis trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Phase: Phase 3 Country / region: France Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20051
20081
20091
20111
20121
20181
20211
20222
20231
20242
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting5
Recruiting4
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
GlaxoSmithKline3
Amgen2
Assistance Publique - Hôpitaux de Paris2
Novartis Pharmaceuticals2
Assistance Publique Hopitaux De Marseille1
AstraZeneca1
CSL Behring1
Ionis Pharmaceuticals, Inc.1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis17
Cardiovascular Diseases7
Heart Diseases5
Ischemic Stroke3
Acute Coronary Syndrome2
Coronary Artery Disease2
Coronary Disease2
Peripheral Arterial Disease2
Stroke2
Angina, Unstable1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.